+Hindustan

( BIOSCIENCES

LTD

Date: 30-07-2016
To
Mr. Bhushan Mokashi
Manager
Bombay Stock Exchange Limited,
Phiroze JeeJeebhoy Towers,
Dalal Srreel,

MUMBAI

4OO OO1.

Sir,
Sub: 1.un-audited financial results for the quafter ended
30.06.2016.
2. Limited Review Report issued by the auditors.
Ref: Our Company code no: 532041.

***

we

are herewith furnishing the un-audited financ.ial results

of the company &
Limited Review Report certified by the auditor for the quarter
ended 30.06.2016"
as per clause 41 of the listing agreement.

Kindly acknowledge the

same

Thanking you,

Yours faithfully,
For
ustan Bio Sciences Limited

Authorized

ignatory

ot No 3 1, saga r s".i.F,ilRb33tft3lf,'331[?:t;i::fi yoera oao - 500 034

Ph. : 040-23555161, 23555L81, Fax : 040-4020517I
Email : info@hindustanbiosciences.in

u,,

HINDUSTAN BIO SCIENCES LIMITED

Plot No.31, sagarsociety, Road No.2, Banjara Hiils, Hyderabad-500 034

Phone No. 235551 6,1, Fax 4020517 1

STATEMENT OF UN AUDITED RESULTS FOR THE QUARTER ENDED 3oth JUNE,2O1
6

Particulars
llncome from operations
l1a; lncome from operations
l1O1 Ottrer operating income
lTotat income from operations (net)
2 lExpenses
l1a1 eurcnase of Traded Goods
l{O) emntoVee benefit expenses
lO Selling Expenses
l(d) OeRreciation and amortisation expenses

Rs. ln lakhs
Year Ended

Quarter ended
30.06.2016

31.03.2016

(Unaudited)

30.06.2015

31.03.2016

'(Audited)

(Unaudited)

(Auditedl

l(e) Other expenses

lTotal expenses
3 lProfit / (Loss) from operations before other income.
lfinance costs and exceptional items (1-2)
4
lOther income
5
/ (Loss) from ordinary activities before finance
lProfit
costs and exceptional items(3+4)
6 Finance costs
7 Profit / (Loss) from ordinary activities after
finance costs but before exceptional items (5-6)
8 Exceptional items
9 Profit / (Loss) from ordinary activities before tax
10 Tax expense
(a) Deferred Tax/Asset(+) Liabitity(-)
(b) Current Tax
11 Net Profit / (Loss) from ordinary activities after tax
Extraordinary items (net of tax expenses)
13 Net Profit / (Loss) for the period
MI Paid-up equity share capital
(Face Value of the Share is Rs.10/- each)
Reserve excluding Revaluation Reserves as
per balance sheet of previous accounting year
Earnings per qhare (Basic and Diluted)
]

nl
I

:l

Notes:

0.00
0.00
0.00

23.35
0.00
23.35

0.00

0.00

50.1 8

126.01

0.00

15.91

33.41

5.41

5.08
0.53
0.27
7.56
46.85

85.79
27.79
1.68

(12.15)

8.98
0.27
0.29
3.93
29.38
(6.03)

alaJJ
J.

23.04
139.40
(13.3s)

0.00

0.00

0.00

0.00

(12.15)

(6.03)
0.64

3.33
0.72

(1s.3e)
2.60

(6.67)
192.30

2.61

0.00

(15.ee)
192.30

(198.s7)

2.61

(208.2e)

(0.4e)
0.00

0.00
0.00

(1se.46)

2.61

(0.4e)
0.00
(208.78)l

0.00
(1ee.46)l
1025.0S

2.61

0.00
0.25
6.49
12.15

0.70
(12.8s)
0.00
(12.85)
0.00
0.00
(12.85)
0.00
(12.8s)l
1025 08

50.1 8

0.00
I

1025.08

PIace: HYDERABAD
Date :30.07.2016

1.10

0.00

(208 78)l

1025.08

(013)I

(543.04)l

(1.s5)l

0.03

1 The un Audited Financial Results were taken on record by the board of Directors
in their meeting held on 30.07.2016

2 Previous year figures have been regrouped wherever necessary

126.01

Q.o4i

VASG & ASSOCIATES

Chartered Accountants

# 503/4, 5th Floor, Kubera Towers,

Narayanaguda, Hyderabad-500 029.
Ph 040 - 6684 9660
Email : vasgassociates@gmail.com
info@vasg-ca.com
website www.vasg-ca com

Limited Review Report

Review Report to
The Board of Directors
Hindustan BioSciences Ltd.

We have reviewed the accompanying statement of unaudited financial results of IWs.

Hindustan Bio Sciences Limited for the period ended 30.06.2016. This statement is the
responsibility of the Company's Management and has been approved by the Board of
Directors. Our responsibility is to issue a report on these financial statements based on
our review.
We conducted our review in accordance with the Standard on Review Engagement (SRE)
2400, Engagements to Review Financial Statements issued by the institute of Chartered
Accountants of India. This standard requires that we plan and perform the review to
obtain moderate assurance as to whether the financial statements are free of material
misstatement. A review is limited primarily to inquiries of company personnel and
analpical procedures applied to financial data and thus provides less assurance that an
audit. We have not performed audit and accordingly, we do not express an audit opinion.
Based on our review conducted as above, nothing has come to our attention that causes us
to believe that the accompanying statement of unaudited financial results prepared in
accordance with applicable accounting standards and other recognized accounting
practices and policies has not been disclosed & the information required to be disclosed
in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements
) Regutations, 2015 including the manner in which it is to be disclosed or that it contains
any material misstatement.

For VASG & ASSOCIATES

Chartered Accountants
Firm Reg No. 0060705

Place: Hyderabad
Date : 30.07.2016

(A.Viswanatha Rao)
Partner
M.No: 29597